Applications
Toepassingen
Onze ingrediënten worden gebruikt in huidverzorging, medische esthetiek, wondzorg en biofarmaceutica.
Functional Skincare & Cosmetics
Anti-aging, repair and firming actives for skincare.
- Ingredients: Type III humanized recombinant collagen, elastin, fibronectin, mussel adhesive protein, metallothionein
- Use cases: anti-aging serums, firming creams, repair masks, meso formulations, sensitive-skin repair
- Advantages: AI protein design + yeast expression, >95% purity with high bioactivity, excellent formula compatibility
- Support: dosage guidance, compatibility testing, INCI names and registration dossier support
Medical Device Raw Materials
Protein raw materials for dressings and medical materials.
- Ingredients: dressing-grade recombinant collagen, fibronectin (first-in-China device master file), mussel adhesive protein (first-batch master file)
- Use cases: wound dressings, medical masks, medical adhesives, post-procedure materials
- Compliance: produced at the Hainan GMP facility, backed by the first recombinant collagen dressing certificate in Hainan
- Supply: 100,000-class and 10,000-class cleanrooms, 3 formulation lines and 7 filling lines
Medical Aesthetics & Injectables
Injectable-grade ingredients and aesthetic formulation solutions.
- Ingredients: injectable-grade recombinant collagen, Type III collagen solution, Type I recombinant collagen
- Use cases: filler injections, meso treatments, collagen implant development and registration
- Cascade supply: pharma-grade GMP with vial and pre-filled syringe filling lines
- R&D co-creation: co-development with clinical experts, registration and academic dossier support
Biopharma & Cell Culture
Cell-culture grade proteins and drug delivery ingredients.
- Ingredients: serum albumin, high-purity recombinant proteins
- Use cases: cell culture media supplements, nutrient carriers, biopharma R&D
- Quality: ISO9001 quality management and ISO13485 medical device quality management
- R&D: 45 years of biological protein heritage, 22 SCI papers and 40 Chinese core journal papers
